Synairgen (SNG)

 

Latest News

Holding(s) in Company

Notification of major interests in shares

Interim results for six months ended 30 June 2017

Announcement of half-year/second quarter financial results

Data update and clinical plan for COPD

Miscellaneous medium priority announcements

Holding(s) in Company

Notification of major interests in shares

All News

DateHeadlineSource
08-11-17Holding(s) in CompanyRNS
27-09-17Data update and clinical plan for COPDRNS
27-09-17Interim results for six months ended 30 June 2017RNS
13-09-17Holding(s) in CompanyRNS
06-09-17Synairgen's PXS-5382A to be prepared for Phase I clinical developmentStockMarketWire
06-09-17LOXL2 Inhibitor Update.RNS
28-06-17Synairgen shareholders pass all resolutions at AGMStockMarketWire
28-06-17Result of AGMRNS
05-06-17Posting of Annual Report and Notice of AGMRNS
17-05-17Preliminary ResultsRNS
27-04-17US tax reform plans and ex-dividends push FTSE lower StockMarketWire
27-04-17Synairgen updates on AZD9412StockMarketWire
27-04-17AZD9412 UpdateRNS
27-03-17Holding(s) in CompanyRNS
13-03-17Holding(s) in CompanyRNS
10-03-17Additional Positive Data in Lung FibrosisRNS
17-01-17Holding(s) in CompanyRNS
13-10-16Holding(s) in CompanyRNS
12-10-16Synairgen updates on AZD9412StockMarketWire
12-10-16FTSE up on airlines, house builders after sluggish startStockMarketWire
12-10-16AZD9412 Clinical Trial UpdateRNS
22-09-16Broker Forecast - N+1 Singer issues a broker note on Synairgen PLCStockMarketWire
22-09-16Synairgen widens H1 pretax lossStockMarketWire
22-09-16Interim results for six months ended 30 June 2016RNS
08-09-16Notice of Interim ResultsRNS
14-06-16Result of AGMRNS
07-06-16Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?Motley Fool
17-05-16Posting of Annual Report and Notice of AGMRNS
21-04-16Holding(s) in CompanyRNS
23-03-16Synairgen options exercised StockMarketWire
23-03-16Exercise of OptionsRNS
22-03-16Broker Forecast - finnCap issues a broker note on Synairgen PLCStockMarketWire
22-03-16Preliminary results for the year ended 31 Dec 2015RNS
22-03-16Positive LOXL2 resultsRNS
03-03-16Notice of Preliminary ResultsRNS
16-11-15Adoption of FRS 101 - Reduced Disclosure FrameworkRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:SNG Editorial
  • Regulatory news feed for LSE:SNG Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account